New cutoffs to define penicillin-su

New cutoffs to define penicillin-susceptible (MIC s 0.125 mg/L), intermediate resistant (MIC025-2 mg/L) and resistant (MIC> 4 mg/L) streptococci

New cutoffs to define penicillin-susceptible (MICs0.06 mg/L), intermediate resistant (MIC 0.125-2 mg/L), and resistant (MIC 24 mg/L) pneumococcal strains

Ceftriaxone is an option in endocarditis caused by relatively penicillin resistant (MIC 0.125-2 mg/L) oral streptococci and the Streptococcus bovis group, preferably by outpatient administration

Desensitization in patients with methicillin-susceptible aureus endocarditis and allergy to beta lactams


High-dose vancomycin for staphylococcal endocarditis: 30-60 mg/kg/d, divided into 2-3 doses (trough level 220 mg/L)

High-dose daptomycin to treat S aureus endocarditis in patients allergic to penicillin and infections caused by methicillin-resistant strainsb

Rifampicin for prosthetic valve endocarditis following 3-5 d of effective treatment at a lower dose (900-1200 mg/d, divided into 2-3 doses)

six weeks' duration of endocarditis therapy for prosthetic valve infection due to HACEK group microorganisms

Doxycycline and hydroxychloroquine for Coxiella bumetii(Qfever) endocarditis

High-dose echinocandins to treat endocarditis due to Candida spp.

Voriconazole (combined or not with echinocandins or amphotericin B) to treat endocarditis caused by Aspergillus

New initial empirical therapy regimen for native valve infection: ampicillin, cloxacillin, and gentamicin

This combination enables treatment of all cases of E faecalis endocarditis with no ris f toxicity and regardless of the degree ofaminoglycoside resistance. Administration with a second antibiotic is proposed to increase the activity and avo he emergence of resistance.

ผลลัพธ์ (อังกฤษ) 2:

New cutoffs to define penicillin-susceptible (MIC s 0.125 mg / L), Intermediate resistant (MIC025-2 mg / L) and resistant (MIC> 4 mg / L) streptococci New cutoffs to define penicillin-susceptible (MICs0.06 mg /. L), Intermediate resistant (MIC 0.125 to 2 mg / L), and resistant (MIC 24 mg / L) pneumococcal strains ceftriaxone is an Option in endocarditis caused by relatively resistant penicillin (MIC 0.125-2 mg / L) and the oral streptococci. streptococcus bovis Group, preferably by Administration Outpatient Desensitization in patients with methicillin-susceptible aureus endocarditis and allergy to beta lactams High-dose vancomycin for staphylococcal endocarditis: 30-60 mg / kg / D, 2-3 Into divided doses (220 mg level trough. / L) High-dose S aureus endocarditis in patients Daptomycin to Treat allergic to penicillin and infections caused by methicillin-resistant Strainsb Rifampicin for prosthetic endocarditis following 3-5 Valve Treatment at a Lower D of effective dose (900-1200 mg / D,. Into divided 2-3 doses) Six weeks' Duration of Therapy for prosthetic endocarditis infection Valve Due to HACEK Group microorganisms Doxycycline and hydroxychloroquine for Coxiella Bumetii (Qfever) endocarditis High-dose Echinocandins to Treat Candida endocarditis Due to spp. Voriconazole (combined or not. with Echinocandins or amphotericin B) to Treat endocarditis caused by Aspergillus New Initial empirical Therapy regimen for Native Valve infection: ampicillin, Cloxacillin, and gentamicin This combination enables Treatment of all Cases of E faecalis endocarditis with no RIS F toxicity and regardless of the Degree Ofaminoglycoside. resistance. Administration with a second antibiotic is proposed to increase the activity and avo he emergence of resistance.